Clinical Trial: Assess Sacubitril/Allisartan and Amlodipine in Patients With Essential Hypertension Uncontrolled With Sacubitril/Allisartan

U.S., July 16 -- ClinicalTrials.gov registry received information related to the study (NCT07704697) titled 'Assess Sacubitril/Allisartan and Amlodipine in Patients With Essential Hypertension Uncontrolled With Sacubitril/Allisartan' on July 09.

Brief Summary: The main objective of the study will be to assess the efficacy and safety of Sacubitril/Allisartan (240mg) and Amlodipine (5mg) in patients with essential hypertension uncontrolled after 4-week treatment with Sacubitril/Allisartan (240mg).

Study Start Date: Nov. 23, 2024

Study Type: INTERVENTIONAL

Condition: Essential Hypertension

Intervention: DRUG: Experimental: Sacubitril/Allisartan and Amlodipine Group

Drug: Sacubitril/Allisartan and Amlodipine

DRUG: Active Comparator: Sa...